semaglutide off brand Off-brand Ozempic and Wegovy weight-loss drugs are a bad idea, FDA says Off-Label Semaglutide Linked to Deaths,

Ongoing Support STEP 3 Physician guidance for dose adjustments, side-effect management, and long-term success

The TRIUMPH-1 Phase 3 trial showed participants losing up to 28.3% of their body weight at 80 weeks

Pregnancy and Reproductive Considerations GLP-1 medications should not be used during pregnancy based on animal studies showing potential risks to unborn babies

496 Besides the above drugs, structural and functional dysbiosis of intestinal microbiome are induced in obese rodents, 497,498 and they may cause IR and systemic inflammation

Patients taking semaglutide 2.4 mg achieved long-term weight reductions of at least 5%